What is the recommended initial evaluation and management for a 34-year-old man presenting with bilateral inguinal lymphadenopathy?

Initial Evaluation and Management of Bilateral Inguinal Lymphadenopathy in a 34-Year-Old Male

The first priority is to determine if this represents penile/urogenital malignancy, sexually transmitted infection (particularly lymphogranuloma venereum), or systemic disease through focused history, physical examination of the genitalia, and tissue diagnosis.

Critical Initial Assessment

History Taking - Specific Red Flags

• Genital lesions: Any penile, scrotal, or perianal ulcers, masses, or skin changes 1
• Sexual history: Recent unprotected intercourse, men who have sex with men (MSM) status, multiple partners 2, 3
• Systemic symptoms: Fever, night sweats, unintentional weight loss (malignancy indicators) 4, 5
• Duration: Lymphadenopathy >4 weeks increases concern for malignancy or chronic infection 4
• Infectious exposures: Cat scratches, tuberculosis contacts, recent travel 2, 6
• Medication/vaccine history: Recent immunizations or drug use 4

Physical Examination - Specific Characteristics to Document

Lymph node assessment 1:

• Size (nodes >2 cm more concerning) 4
• Number of nodes in each groin
• Mobility vs. fixation to skin or deeper structures
• Matted/fused quality
• Tenderness and overlying skin changes
• Presence of edema in penis, scrotum, or legs

Mandatory genital examination 1:

• Inspect entire penis: Look for ulcers, masses, erythema, or skin lesions at glans, shaft, or base
• Palpate for masses: Assess for corporal involvement
• Examine scrotum, perineum, and perianal region
• Document any lesion size, location, and characteristics

Diagnostic Algorithm

If Genital Lesion Present:

1. Biopsy the primary lesion (unless malignancy clinically obvious) 7
2. Fine-needle aspiration (FNA) of inguinal nodes - this is standard for palpable bilateral nodes 1
   • If FNA negative: Confirm with excisional biopsy 1
   • If FNA positive for malignancy: Proceed to staging workup
3. Imaging for staging (if malignancy suspected):
   • MRI of pelvis to assess extent and pelvic lymph nodes 1
   • CT chest/abdomen or PET-CT to exclude distant metastases 1, 7

If No Genital Lesion Visible:

1. STI testing panel including:
   • Chlamydia trachomatis with LGV-specific DNA testing (urine NAAT) 3
   • Syphilis serology
   • HIV testing 3
2. Laboratory workup 4, 5:
   • Complete blood count
   • ESR/CRP
   • Tuberculosis testing (especially if endemic area or risk factors) 6
3. Imaging: Ultrasound of inguinal regions with FNA of sonographically abnormal nodes 7, 8
4. If workup negative and nodes persist >4 weeks: Excisional biopsy for histopathology 4, 5

Common Pitfalls to Avoid

Do not delay tissue diagnosis in high-risk scenarios 1. In patients with suspected high-risk penile lesions, omit FNA and proceed directly to lymphadenectomy to avoid treatment delays 1.

Do not assume inflammation alone - 30-50% of palpable inguinal nodes in penile cancer patients are inflammatory rather than metastatic 1, but tissue confirmation is mandatory.

Do not miss LGV in MSM population - isolated painful bilateral inguinal lymphadenopathy without other symptoms can be LGV, which requires specific testing 3.

Avoid corticosteroids before diagnosis - they can mask lymphoma or other malignancies histologically 4, 5.

Management Based on Diagnosis

If Penile Cancer Confirmed:

• Bilateral palpable nodes warrant bilateral inguinal lymph node dissection (ILND) after FNA confirmation 9, 1
• If nodes are fixed/ulcerated: Consider neoadjuvant chemotherapy (cisplatin-based) followed by consolidation surgery 9
• Early lymph node treatment improves survival except in bulky/metastatic disease 1

If STI (LGV) Confirmed:

• Doxycycline 100mg twice daily for 21 days
• Test and treat sexual partners 2, 3

If Tuberculosis Confirmed:

• Standard anti-tubercular therapy with documented regression 6

If Benign/Reactive:

• Observation with re-examination in 2-4 weeks
• Biopsy if persistence beyond 4 weeks 4, 5